MX2010003935A - Suministro de farmaco por inhalacion. - Google Patents
Suministro de farmaco por inhalacion.Info
- Publication number
- MX2010003935A MX2010003935A MX2010003935A MX2010003935A MX2010003935A MX 2010003935 A MX2010003935 A MX 2010003935A MX 2010003935 A MX2010003935 A MX 2010003935A MX 2010003935 A MX2010003935 A MX 2010003935A MX 2010003935 A MX2010003935 A MX 2010003935A
- Authority
- MX
- Mexico
- Prior art keywords
- containers
- drug delivery
- active agents
- nebulization
- inhalation drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen en la presente envases, métodos y equipos de dosis unitaria para el tramiento del asma y otras condiciones pulmonares mediante nebulización. Las dosis unitarias de los agentes activos se proporcionan en una formulación de bajo volumen, que da como resultado la nebulización más rápida de la dosis unitaria. Los envases también se forman para minimizar el área de superficie interna, de manera que pueda lograrse la re-dispersión efectiva de los agentes activos mientras se reduce la adsorción en las paredes de los envases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97979107P | 2007-10-12 | 2007-10-12 | |
PCT/US2008/079754 WO2009049304A1 (en) | 2007-10-12 | 2008-10-13 | Inhalation drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010003935A true MX2010003935A (es) | 2010-09-24 |
Family
ID=40070692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010003935A MX2010003935A (es) | 2007-10-12 | 2008-10-13 | Suministro de farmaco por inhalacion. |
Country Status (4)
Country | Link |
---|---|
US (1) | US8486043B2 (es) |
CA (1) | CA2702261A1 (es) |
MX (1) | MX2010003935A (es) |
WO (1) | WO2009049304A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
EP1607117A4 (en) | 2003-03-27 | 2007-10-24 | Bioactis Ltd | APPLICATOR FOR POWDER MEDICATION IN THE NOSE CAVE |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
EP1785145A4 (en) * | 2004-08-10 | 2008-08-13 | Translational Res Ltd | TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY |
JP5415769B2 (ja) | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
EP2429495A4 (en) * | 2009-05-15 | 2014-01-22 | Shin Nippon Biomedical Lab Ltd | INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS |
IT1394223B1 (it) * | 2009-05-15 | 2012-06-01 | Thea Sas Lab | Kit per la valutazione e la selezione personalizzata di lacrime artificiali |
WO2011013003A2 (en) * | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
MX2012004177A (es) * | 2009-10-12 | 2012-05-08 | Boehringer Ingelheim Vetmed | Recipiente para composiciones que comprenden meloxicam. |
JP2013515513A (ja) * | 2009-12-24 | 2013-05-09 | ビーエム ゴル プロプライエタリー リミテッド | 使い捨ての容器およびその用途 |
US9545488B2 (en) | 2010-01-12 | 2017-01-17 | Dance Biopharm Inc. | Preservative-free single dose inhaler systems |
US10842951B2 (en) | 2010-01-12 | 2020-11-24 | Aerami Therapeutics, Inc. | Liquid insulin formulations and methods relating thereto |
US20130269684A1 (en) | 2012-04-16 | 2013-10-17 | Dance Pharmaceuticals, Inc. | Methods and systems for supplying aerosolization devices with liquid medicaments |
US9180261B2 (en) | 2010-01-12 | 2015-11-10 | Dance Biopharm Inc. | Preservative free insulin formulations and systems and methods for aerosolizing |
SG183846A1 (en) | 2010-03-03 | 2012-10-30 | Boehringer Ingelheim Vetmed | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
US9132243B2 (en) * | 2010-07-23 | 2015-09-15 | Tannermedico A/S | Method of administering a substance to the throat |
AU2011305566A1 (en) | 2010-09-22 | 2013-05-02 | Map Pharmaceuticals, Inc. | Aerosol composition for administering drugs |
FR2967136B1 (fr) * | 2010-11-08 | 2013-11-01 | Unither Dev | Procede de fabrication de fioles marquees, chaine de fabrication de fioles marquees et fioles marquees |
FR2974755B1 (fr) * | 2011-05-04 | 2014-03-21 | Unither Pharmaceuticals | Procede de marquage d'un contenant unidose de faible volume, contenant ainsi marque |
US9636355B2 (en) | 2011-09-22 | 2017-05-02 | Theo Holdings, Llc | Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion |
US10658689B2 (en) * | 2012-01-25 | 2020-05-19 | Intelligent Energy Limited | Authentication of replaceable fuel cartridge |
KR102357044B1 (ko) | 2012-12-04 | 2022-02-08 | 말린크로트 파마슈티칼스 아일랜드 리미티드 | 일산화질소 전달 동안 투약량의 희석을 최소화하기 위한 캐뉼라 |
US9795756B2 (en) | 2012-12-04 | 2017-10-24 | Mallinckrodt Hospital Products IP Limited | Cannula for minimizing dilution of dosing during nitric oxide delivery |
US9587167B2 (en) * | 2013-10-18 | 2017-03-07 | Chemical Flooding Technologies, LLC | For storage of surfactant concentrate solution |
USD744108S1 (en) | 2014-02-19 | 2015-11-24 | Resmed Limited | Humidifier reservoir for positive airway pressure delivery console |
US10471222B2 (en) | 2014-07-01 | 2019-11-12 | Dance Biopharm Inc. | Aerosolization system with flow restrictor and feedback device |
US10857313B2 (en) | 2014-07-01 | 2020-12-08 | Aerami Therapeutics, Inc. | Liquid nebulization systems and methods |
US11273271B2 (en) | 2014-07-01 | 2022-03-15 | Aerami Therapeutics, Inc. | Aerosolization system with flow restrictor and feedback device |
US9918900B2 (en) | 2014-10-29 | 2018-03-20 | R.P. Scherer Technologies, Llc | Inverse blow-fill-seal packaging |
US10363369B2 (en) * | 2015-01-14 | 2019-07-30 | Weiler Engineering, Inc. | Ampoule with dual Luer fitting |
CN107530372A (zh) | 2015-02-25 | 2018-01-02 | 当斯生物制药有限公司 | 液体胰岛素制剂及与其相关的方法 |
USD848620S1 (en) * | 2016-11-28 | 2019-05-14 | Spirosure, Inc. | Mouthpiece for a respiratory monitor |
CN106767300B (zh) * | 2017-03-04 | 2022-08-19 | 一重集团常州市华冶轧辊股份有限公司 | 辊筒外径测量校准辊及辊筒外径标定方法 |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
WO2019099954A1 (en) | 2017-11-17 | 2019-05-23 | Koska Family Limited | Systems and methods for fluid delivery manifolds |
USD921900S1 (en) | 2018-12-19 | 2021-06-08 | ResMed Pty Ltd | Humidification tub |
CN112976543B (zh) * | 2021-02-05 | 2023-01-10 | 抚州市医宝城医疗器械有限公司 | 一种用于生产连排塑料安剖瓶的生产工艺、模具及产品 |
USD992110S1 (en) | 2021-08-10 | 2023-07-11 | Koska Family Limited | Sealed fluid container |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4477452A (en) * | 1981-03-26 | 1984-10-16 | American Cyanamid Company | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
US5035689A (en) * | 1989-03-13 | 1991-07-30 | Schroeder Thomas J | Luer-loc-tipped vial--syringe combination |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
WO1996025918A1 (en) * | 1995-02-24 | 1996-08-29 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
US6571790B1 (en) * | 1997-05-12 | 2003-06-03 | Robert E. Weinstein | Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
US6267989B1 (en) * | 1999-03-08 | 2001-07-31 | Klan Pharma International Ltd. | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
US20030091513A1 (en) * | 2001-10-03 | 2003-05-15 | Mohsen Nahed M. | Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension or dispersion media |
US7029465B2 (en) * | 2002-04-11 | 2006-04-18 | Pharmacia Corporation | Filter ampoule system |
US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
WO2005122719A2 (en) * | 2004-06-08 | 2005-12-29 | Coifman Robert E | Ampules for small unit dose volumes of drug |
US20090081297A1 (en) * | 2005-04-27 | 2009-03-26 | Cook Robert O | Use of surface tension reducing agents in aerosol formulations |
GB0513581D0 (en) * | 2005-07-01 | 2005-08-10 | Norton Healthcare Ltd | Container |
EP1811134A1 (de) * | 2006-01-23 | 2007-07-25 | ABB Turbo Systems AG | Verstellbare Leitvorrichtung |
US20070178051A1 (en) * | 2006-01-27 | 2007-08-02 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
-
2008
- 2008-10-13 MX MX2010003935A patent/MX2010003935A/es active IP Right Grant
- 2008-10-13 WO PCT/US2008/079754 patent/WO2009049304A1/en active Application Filing
- 2008-10-13 US US12/250,516 patent/US8486043B2/en not_active Expired - Fee Related
- 2008-10-13 CA CA2702261A patent/CA2702261A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090157037A1 (en) | 2009-06-18 |
US8486043B2 (en) | 2013-07-16 |
WO2009049304A1 (en) | 2009-04-16 |
CA2702261A1 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010003935A (es) | Suministro de farmaco por inhalacion. | |
WO2009112273A3 (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
WO2009112274A3 (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
PH12016500619A1 (en) | Dry powder inhaler | |
PH12014502746B1 (en) | Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same | |
JP2013224331A5 (es) | ||
BRPI0607574A2 (pt) | composição farmacêutica aerossol | |
WO2011053792A3 (en) | Methods and compositions for sustained delivery of drugs | |
WO2008030538A3 (en) | Cancer stem cell-targeted cancer therapy | |
TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
WO2010011329A3 (en) | The delivery of powdered drug via inhalation | |
MX2009012598A (es) | Formas de dosis que comprenden vx-950 y su regimen de dosificacion. | |
AR091161A1 (es) | Composicion farmaceutica para inhalacion, metodo, uso | |
MX2012004338A (es) | Formulaciones mejoradas. | |
EP4233874A3 (en) | Acetylsalicylic acid for reducing the risk of a thromboembolic event | |
WO2012040228A3 (en) | Aerosol composition for administering drugs | |
WO2010042701A3 (en) | Corticosteroid compositions for use in treating diseases of the upper and lower airway passages | |
NZ701261A (en) | Novel dosage form and formulation of abediterol | |
TN2009000390A1 (en) | Use of a composition comprising formoterol and beclometasone dipropionate for the prevention and/or treatment of an exacerbation of asthma | |
BR112013024791A2 (pt) | aclidínio para uso na melhoria da qualidade do sono em pacientes com sintomas respiratórios, composição farmacêutica compreendendo o mesmo e seus usos. | |
MY179794A (en) | Compound composition for inhalation used for treating asthma | |
MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
WO2015066664A3 (en) | Compositions and methods for administration of an enzyme to a subject's airway | |
MX2021001845A (es) | Un medicamento combinado que comprende fenilefrina y paracetamol. | |
WO2009062193A3 (en) | Methods for administering corticosteroid formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |